R935788 (Fostamatinib disodium) is a potent orally available inhibitor of Syk that inhibits tumor growth in the E??- TCL1 transgenic mouse model of CLL by blocking antigen-dependent B-cell receptor signaling.
More Information Supplier PageR935788 (Fostamatinib disodium) is a potent orally available inhibitor of Syk that inhibits tumor growth in the E??- TCL1 transgenic mouse model of CLL by blocking antigen-dependent B-cell receptor signaling.
More Information Supplier PageR406 is a potent inhibitor of immunoglobulin E (IgE)- and IgG-mediated activation of Fc receptor signaling.
More Information Supplier PageR406 is a potent inhibitor of immunoglobulin E (IgE)- and IgG-mediated activation of Fc receptor signaling.
More Information Supplier PageR406 is a potent inhibitor of immunoglobulin E (IgE)- and IgG-mediated activation of Fc receptor signaling.
More Information Supplier PageR406 is a potent inhibitor of immunoglobulin E (IgE)- and IgG-mediated activation of Fc receptor signaling.
More Information Supplier PageRacecadotril is a potent enkephalinase inhibitor which exhibits selective antisecretory activity.
More Information Supplier PageRacecadotril is a potent enkephalinase inhibitor which exhibits selective antisecretory activity.
More Information Supplier PageRaf265 derivative is a derivative of Raf265 that is an oral, highly selective RAF and VEGFR kinase inhibitor with IC50 of of 5 to 10 ??M.
More Information Supplier PageRaf265 derivative is a derivative of Raf265 that is an oral, highly selective RAF and VEGFR kinase inhibitor with IC50 of of 5 to 10 ??M.
More Information Supplier Page
